HGH fragment 176-191 benefits may include fat loss without the blood sugar spikes linked to full HGH. Learn how the peptide works and what research shows.
HGH fragment 176-191 is a synthetic peptide that copies the last 16 amino acids of human growth hormone, and it is researched mainly for fat loss without the blood sugar spikes linked to full HGH. Animal studies and a few small human trials suggest it can increase fat breakdown, but the results in people have been modest. HGH fragment 176-191 is not FDA-approved for human use in the United States.
What Is HGH Fragment 176-191?
Human growth hormone is a chain of 191 amino acids. In the 1990s, researchers isolated the tail end of that chain — amino acids 176 through 191 — and found that this short piece acted on fat cells on its own.
The same peptide is also sold under the name AOD9604. Vendors use both labels, and the two names are usually treated as interchangeable.
- Structure: a 16-amino-acid fragment of human growth hormone.
- Main research focus: fat metabolism and lipolysis.
- Common research protocol: subcutaneous injection, once or twice daily.
- US legal status: not an approved drug for human use.
HGH Fragment 176-191 Benefits Studied in Research
Most claims about this peptide trace back to rodent studies and a small number of human trials. These are the findings that come up most often.
Fat breakdown and fat loss
The fragment mimics part of HGH's effect on fat cells. It appears to encourage lipolysis, the release of stored fat, and to discourage new fat storage. In obese mice, it lowered body weight and fat mass.
Human data is thinner. In a 12-week trial of AOD9604, participants lost small amounts of body fat compared with placebo, and the effect was not dramatic. HGH fragment 176-191 is therefore best described as a researched fat-loss peptide, not a proven weight-loss treatment.
Little effect on blood sugar
Full growth hormone can raise blood sugar and work against insulin. The 176-191 fragment has not shown that pattern in published studies, which is the main reason it is marketed as a cleaner alternative to full growth hormone.
No meaningful IGF-1 increase
HGH works partly by raising IGF-1, the hormone that drives growth effects throughout the body. The fragment does not raise IGF-1 the same way. That may lower some risks, but it also means the peptide cannot deliver the muscle-building and recovery effects people associate with hgh benefits for men.
Joint and cartilage effects
Some animal research reported cartilage repair and less joint damage with the fragment. No human trial has confirmed joint benefits, so this claim remains unproven.
HGH Fragment 176-191 vs Somatropin
Somatropin is the prescription form of full human growth hormone. A side-by-side look at hgh fragment 176-191 vs somatropin shows the gap in potency and side effects.
| Feature | HGH fragment 176-191 | Somatropin (full HGH) |
|---|---|---|
| Structure | 16-amino-acid tail fragment | Complete 191-amino-acid hormone |
| Primary studied effect | Fat breakdown | Growth, lean mass, fat, connective tissue |
| Blood sugar | Little to no rise in studies | Can raise blood sugar and insulin resistance |
| IGF-1 | Little to no increase | Significant increase |
| Muscle growth | No reliable evidence | Increases lean mass with long-term use |
| FDA status | Not approved for human use | Approved for specific medical conditions |
| How it is obtained | Sold as a research chemical | Prescription only in the US |
Is AOD9604 the Same as HGH Fragment 176-191?
In most cases, yes. AOD9604 is the name used during pharmaceutical development of the C-terminal fragment, while HGH frag is the nickname used in research and bodybuilding circles.
Because research peptides are not verified for identity or purity, two vials with the same label can contain different amounts of peptide. That is one reason comparisons of aod 9604 vs hgh frag 176-191 often produce inconsistent results: the real difference is usually the vendor, not the molecule.
For a broader look at the parent compound, aod 9604 vs hgh explains how full growth hormone and the fragment differ in strength and side effect profile.
Stacking: Fragment 176-191, CJC-1295, and Ipamorelin
Some suppliers sell the fragment together with growth-hormone-releasing peptides. A common combination marketed online is the fragment 176-191 & cjc-1295 & ipamorelin blend, which pairs a fat-loss peptide with two compounds that prompt the body to release its own growth hormone.
There is no human trial data on that specific three-peptide blend. Each ingredient has its own limited research history, and stacking them multiplies the unknowns, particularly around pituitary response and blood sugar.
Theory and marketing are not the same as evidence. A blend that looks logical on paper can still produce side effects that no single ingredient would cause alone.
Dosage, Side Effects, and Safety
No standard human dose exists. Protocols shared online commonly mention 200 to 500 mcg injected under the skin once or twice a day, often on an empty stomach, in cycles of 8 to 12 weeks. Those numbers come from user reports, not clinical guidelines.
Reported side effects are usually mild:
- Redness, swelling, or pain at the injection site
- Headache or lightheadedness
- Fatigue
- Nausea
The larger risk is product quality. Unregulated vials may contain the wrong peptide, the wrong amount, or bacterial contamination. Injecting an unverified product can cause infection or an allergic reaction.
The peptide should never replace medical care, a balanced diet, or regular exercise. Anyone who is pregnant, has a health condition, or takes prescription medication should speak with a healthcare professional before using any research peptide.
Bottom line: HGH fragment 176-191 has a plausible fat-loss mechanism and encouraging animal data, but human evidence is weak and the product is unapproved. It is a research compound, not a proven treatment.
Frequently Asked Questions
What does HGH fragment 176-191 do?
HGH fragment 176-191 mimics the fat-regulating tail end of human growth hormone and acts mainly on fat cells, encouraging stored fat to be released. It does not appear to raise blood sugar or IGF-1 the way full HGH does. Fat loss results in human trials have been modest, and the peptide is not FDA-approved for human use.
Does HGH fragment 176-191 actually burn fat?
Animal studies show clear reductions in body fat with the fragment, but human evidence is weaker. A 12-week trial of AOD9604 found only small body fat reductions compared with placebo. It is a researched compound, not a proven weight-loss drug.
Is HGH fragment 176-191 safe?
There is no long-term human safety data for HGH fragment 176-191. Short studies and user reports mention injection-site reactions, headache, and fatigue, and unregulated vials carry risks of contamination or incorrect dosing. Talk with a healthcare professional before considering any research peptide.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.